The Central Bureau of Communication (CBC), Ministry of Information and Broadcasting, Government of India, Regional Office ...

The Pokemon series has been in need of serious evolution recently. 2022’s “Pokemon Legends: Arceus” switched up the ...

Duchenne (SGT-003): 23 participants have been dosed in the INSPIRE DUCHENNE trial as of October 31, 2025; Solid expects to ...

The results of the ALLEGORY trial of Gazyva (obinutuzumab) suggest that the anti-CD20 antibody could have broad utility in ...

Thank you, operator. Good morning and good afternoon, everybody, and thank you for joining BioNTech's Third Quarter 2025 Earnings Call. As a reminder, the slides we'll use during the call and the ...

Q3 2025 Earnings Call November 3, 2025 5:00 AM ESTCompany ParticipantsInge Laudy - Manager of Investor RelationsLinde Jansen ...

Third Quarter 2025 Revenue of $72m and Non-GAAP Adjusted Earnings of $41mExecuted 15-Year data center campus lease with Amazon Web Services to ...

Can you give a couple of examples regarding the challenges faced ... I think one company leaving the state will not be a ...

The big problem is that racing, while seemingly breathtaking and urgent, is actually a little dull in Fast & Furious: Arcade Edition.

First-in-Human Phase 1 data for allogeneic CAR-T cell therapy for NHL to be featured in oral session ...

Hims & Hers Health, Inc. ("Hims & Hers" or the "Company", NYSE: HIMS), the leading health and wellness platform, today announced financial results for the third quarter ended September 30, 2025, in a ...

Ascendis Pharma A/S (Nasdaq: ASND) today announced that its data showing sustained improvements in renal function, continued normalization of urine calcium handling, and continued safety and efficacy ...